Cheryl Watkins-Moore, DPM

Cheryl Watkins-Moore

Dr. Cheryl Watkins-Moore is co-founder and previous CEO of Accelerated Rehabilitation Technologies, LLC, a technology development company focused in the rehabilitation market. Dr. Moore currently serves as the director, bioscience entrepreneurial inclusion for BioSTL. In this role, Cheryl is responsible for creating processes and programming that will increase the mission impact of BioSTL and the regional bioscience ecosystem by improving the performance and contribution of underrepresented populations in the regional bioscience sector. BioSTL is a nonprofit organization that builds regional capacity, nurtures a collaborative environment and focuses community leadership and resources to capitalize on the unique convergence of St. Louis‘ corporate, university, and entrepreneurial strengths in medical and plant bioscience. Cheryl was recently appointed adjunct professor, Northwestern University Law School, in their masters of science in law program. 
 
Previously, Dr. Moore served as an entrepreneur in residence (EIR) with BioGenerator, a private investment firm created by BioSTL to identify promising technologies/services and facilitate the formation of successful, sustainable life science companies in the St. Louis, MO region. Cheryl has identified and provided mentoring as well as due diligence to early stage organizations with unique technologies in various markets such as asthma, cancer, rehabilitation and physical therapy markets, raising initial capital funding. She was invited by Washington University’s Skandalaris entrepreneurial program and capital innovators to mentor early stage companies in business analysis and business plan development. Dr. Moore has also served as a judge in several local and national business plan competitions including Washington University’s Skandalaris’ Business Plan Competition, Steve Case’s Rise of the Rest National Tour (St. Louis) and Global Startup Weekend HEALTH:Bio (St. Louis).  
 
Dr. Moore has also served as vice president/general manager for the integrated biomarker solutions business initiative of EMD Millipore, the US subsidiary of Merck KGaA. Prior to this role, she served as vice president/general manager for EMD Merck analytics division, a +$100M chemical and specialty analytics business, where she had full P&L responsibility and managed marketing, sales, technical service, pricing as well as distribution.
 
Dr. Moore holds a masters of business management from the Kellogg School of Management, Northwestern University and a bachelor of arts, biology from Fisk University. She is a doctor of podiatric medicine, earning her degree from Illinois College of Podiatric Medicine. She has led marketing teams that have won several awards for marketing innovations, including the American Marketing Association highest award, The Award of Excellence and The Bronze Quill award. She is a board of trustees member, Academy of Science-St. Louis; board member, Prosper Institute, Prosper Women Entrepreneurs; advisory board member, BALSA Foundation; advisory board member, SanusEO; board member The Biome School; advisory STEM board member, Harris-Stowe State University; board member, Innovative Technology Education Fund; advisory board member, Society of Physician Entrepreneurs, St. Louis and is active in the St. Louis, MO chapter of Jack and Jill of America.